We hypothesize that Que suppresses glycolysis and exerts anti-ALL effects by inhibiting the cAMP/PKA/CREB signaling pathway, thereby modulating the transcription of HK-2, PFKP, and PKM2. The gene discussed is CREB1; the disease is acute lymphoblastic leukemia.